secwatch.observer — SEC 8-K summary
======================================

Issuer:     BRISTOL MYERS SQUIBB CO (BMY)
CIK:        0000014272
Form:       8-K
Filed at:   2022-03-03T23:59:59+00:00
Accession:  0001140361-22-007672
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bristol-Myers Squibb upsizes note tender offers, accepts ~$5.15B principal, early settlement March 4
--------------------------------------------------------------------------------

- Upsized maximum aggregate purchase price from $4.0B to accept all valid tenders; accepted ~$5.15B principal across 22 series.
- Early settlement date set for March 4, 2022; interest ceases on that date for accepted notes.
- Tendered notes accepted with yields ranging from 1.842% (2026 notes) to 4.122% (2097 notes) plus fixed spreads.
- Some series subject to proration: 2026 Pool accepted 34.38% of tendered; 2029 Pool 69.09%; High Coupon Pool certain series prorated.
- Certain high-coupon notes (4.25%, 4.625%, 4.35% due 2044–2049) not accepted due to hitting pool maximums.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/14272/000114036122007672/0001140361-22-007672-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/14272/000114036122007672/ny20002727x7_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-22-007672

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer